Literature DB >> 23827383

A genome-wide association study for malignant mesothelioma risk.

Gemma Cadby1, Sutapa Mukherjee, A W Bill Musk, Alison Reid, Mike Garlepp, Ian Dick, Cleo Robinson, Jennie Hui, Giovanni Fiorito, Simonetta Guarrera, John Beilby, Phillip E Melton, Eric K Moses, Donatella Ugolini, Dario Mirabelli, Stefano Bonassi, Corrado Magnani, Irma Dianzani, Giuseppe Matullo, Bruce Robinson, Jenette Creaney, Lyle J Palmer.   

Abstract

Malignant mesothelioma (MM) is a uniformly fatal tumour of mesothelial cells. MM is caused by exposure to asbestos however most individuals with documented asbestos exposure do not develop MM. Although MM appears to aggregate within families, the genetics of MM susceptibility is a relatively unexplored area. The aim of the current study was to identify genetic factors that contribute to MM risk. A genome-wide association analysis of 2,508,203 single nucleotide polymorphisms (SNPs) from 428 MM cases and 1269 controls from Western Australia was performed. Additional genotyping was performed on a sample of 778 asbestos-exposed Western Australian controls. Replication of the most strongly associated SNPs was undertaken in an independent case-control study of 392 asbestos-exposed cases and 367 asbestos-exposed controls from Italy. No SNPs achieved formal genome-wide statistical significance in the Western Australian study. However, suggestive results for MM risk were identified in the SDK1, CRTAM and RASGRF2 genes, and in the 2p12 chromosomal region. These findings were not replicated in the Italian study, although there was some evidence of replication in the region of SDK1. These suggestive associations will be further investigated in sequencing and functional studies.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Asbestos; Case–control studies; Genetics; Genome-wide association study; Mesothelioma

Mesh:

Substances:

Year:  2013        PMID: 23827383     DOI: 10.1016/j.lungcan.2013.04.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.

Authors:  Satu Mäki-Nevala; Virinder Kaur Sarhadi; Aija Knuuttila; Ilari Scheinin; Pekka Ellonen; Sonja Lagström; Mikko Rönty; Eeva Kettunen; Kirsti Husgafvel-Pursiainen; Henrik Wolff; Sakari Knuutila
Journal:  Lung       Date:  2016-02       Impact factor: 2.584

Review 2.  The genetic susceptibility in the development of malignant pleural mesothelioma.

Authors:  Ombretta Melaiu; Federica Gemignani; Stefano Landi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  Changing pattern in malignant mesothelioma survival.

Authors:  Jennifer Faig; Suzanne Howard; Edward A Levine; Gary Casselman; Mary Hesdorffer; Jill A Ohar
Journal:  Transl Oncol       Date:  2015-02       Impact factor: 4.243

4.  Paired Expression Analysis of Tumor Cell Surface Antigens.

Authors:  Rimas J Orentas; Sivasish Sindiri; Christine Duris; Xinyu Wen; Jianbin He; Jun S Wei; Jason Jarzembowski; Javed Khan
Journal:  Front Oncol       Date:  2017-08-21       Impact factor: 6.244

Review 5.  Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review.

Authors:  Vasiliki Panou; Oluf Dimitri Røe
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

Review 6.  Genomics and Epigenetics of Malignant Mesothelioma.

Authors:  Adam P Sage; Victor D Martinez; Brenda C Minatel; Michelle E Pewarchuk; Erin A Marshall; Gavin M MacAulay; Roland Hubaux; Dustin D Pearson; Aaron A Goodarzi; Graham Dellaire; Wan L Lam
Journal:  High Throughput       Date:  2018-07-27

7.  DNA Methylation in Babies Born to Nonsmoking Mothers Exposed to Secondhand Smoke during Pregnancy: An Epigenome-Wide Association Study.

Authors:  Bernard F Fuemmeler; Mikhail G Dozmorov; Elizabeth K Do; Junfeng Jim Zhang; Carole Grenier; Zhiqing Huang; Rachel L Maguire; Scott H Kollins; Cathrine Hoyo; Susan K Murphy
Journal:  Environ Health Perspect       Date:  2021-05-19       Impact factor: 9.031

8.  SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report.

Authors:  Lin Ma; Junjuan Xiao; Yaping Guan; Dongfang Wu; Tiantian Gu; Jun Wang
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

9.  A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma.

Authors:  Marvin Martens; Franziska Kreidl; Friederike Ehrhart; Didier Jean; Merlin Mei; Holly M Mortensen; Alistair Nash; Penny Nymark; Chris T Evelo; Ferdinando Cerciello
Journal:  Front Oncol       Date:  2022-04-26       Impact factor: 5.738

10.  Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy).

Authors:  Silvia D Visonà; Simona Villani; Federica Manzoni; Yao Chen; Giorgio Ardissino; Francesca Russo; Matteo Moretti; Gulnaz T Javan; Antonio Osculati
Journal:  J Public Health Res       Date:  2018-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.